Galantamine for Alzheimer's disease and mild cognitive impairment.
Cusi
Cristina
C
Cantisani
Teresa Anna
TA
Celani
Maria Grazia
MG
Incorvaia
Barbara
B
Righetti
Enrico
E
Candelise
Livia
L
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D003072:Cognition Disorders / Q000188:drug therapy* / Q000523:psychology; D003692:Delayed-Action Preparations; D005702:Galantamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D018697:Nootropic Agents; D005702:Galantamine